MAI Capital Management’s Eli Lilly LLY Stock Holding History

MAI Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$88.4M	Buy	96,089 +4,767	+5%	+$4.83M	0.5%	40
2025 Q4	$98.1M	Buy	91,322 +6,425	+8%	+$6.14M	0.56%	36
2025 Q3	$64.8M	Buy	84,897 +2,402	+3%	+$1.79M	0.4%	51
2025 Q2	$64.3M	Sell	82,495 -27,061	-25%	-$21M	0.44%	52
2025 Q1	$90.5M	Buy	109,556 +839	+0.8%	+$698K	0.68%	34
2024 Q4	$83.9M	Buy	108,717 +9,065	+9%	+$7.51M	0.62%	36
2024 Q3	$88.3M	Sell	99,652 -2,772	-3%	-$2.49M	0.84%	26
2024 Q2	$92.7M	Buy	102,424 +3,279	+3%	+$2.62M	0.91%	22
2024 Q1	$77.1M	Buy	99,145 +5,511	+6%	+$3.92M	0.8%	26
2023 Q4	$54.6M	Buy	93,634 +2,135	+2%	+$1.25M	0.72%	33
2023 Q3	$49.1M	Sell	91,499 -1,619	-2%	-$834K	0.73%	31
2023 Q2	$43.7M	Buy	93,118 +95	+0.1%	+$39.8K	0.64%	36
2023 Q1	$31.9M	Sell	93,023 -8,003	-8%	-$2.7M	0.5%	51
2022 Q4	$37M	Sell	101,026 -11,135	-10%	-$3.95M	0.62%	40
2022 Q3	$36.3M	Sell	112,161 -5,508	-5%	-$1.75M	0.68%	33
2022 Q2	$38.2M	Buy	117,669 +4,191	+4%	+$1.26M	0.73%	33
2022 Q1	$32.5M	Buy	113,478 +437	+0.4%	+$112K	0.55%	45
2021 Q4	$31.2M	Buy	113,041 +5,132	+5%	+$1.3M	0.5%	48
2021 Q3	$24.9M	Buy	107,909 +1,760	+2%	+$434K	0.48%	52
2021 Q2	$24.4M	Sell	106,149 -14,816	-12%	-$2.98M	0.48%	50
2021 Q1	$22.6M	Buy	120,965 +3,435	+3%	+$672K	0.51%	51
2020 Q4	$19.8M	Buy	117,530 +106,512	+967%	+$15.9M	0.5%	51
2020 Q3	$1.63M	Sell	11,018 -130	-1%	-$20.1K	0.05%	198
2020 Q2	$1.83M	Sell	11,148 -196	-2%	-$30.1K	0.06%	175
2020 Q1	$1.57M	Buy	11,344 +2,712	+31%	+$373K	0.06%	169
2019 Q4	$1.13M	Buy	8,632 +3,981	+86%	+$461K	0.04%	258
2019 Q3	$520K	Buy	4,651 +153	+3%	+$17K	0.02%	344
2019 Q2	$498K	Sell	4,498 -1,111	-20%	-$131K	0.02%	352
2019 Q1	$728K	Sell	5,609 -453	-7%	-$55.1K	0.04%	253
2018 Q4	$701K	Buy	6,062 +368	+6%	+$41.1K	0.04%	255
2018 Q3	$611K	Sell	5,694 -277	-5%	-$27.7K	0.03%	286
2018 Q2	$510K	Sell	5,971 -136	-2%	-$11.2K	0.03%	299
2018 Q1	$473K	Buy	6,107 +92	+2%	+$7.41K	0.03%	297
2017 Q4	$508K	Buy	6,015 +119	+2%	+$10.1K	0.03%	291
2017 Q3	$504K	Sell	5,896 -59	-1%	-$4.84K	0.03%	275
2017 Q2	$490K	Buy	5,955 +723	+14%	+$59K	0.03%	278
2017 Q1	$440K	Sell	5,232 -1,844	-26%	-$148K	0.03%	279
2016 Q4	$520K	Buy	7,076 +500	+8%	+$37.2K	0.04%	252
2016 Q3	$528K	Buy	6,576 +154	+2%	+$12.3K	0.04%	264
2016 Q2	$506K	Sell	6,422 -1,639	-20%	-$123K	0.04%	266
2016 Q1	$580K	Buy	8,061 +500	+7%	+$37.8K	0.04%	248
2015 Q4	$637K	Buy	7,561 +59	+0.8%	+$4.9K	0.05%	237
2015 Q3	$628K	Sell	7,502 -320	-4%	-$27K	0.05%	249
2015 Q2	$653K	Buy	7,822 +41	+0.5%	+$3.12K	0.04%	263
2015 Q1	$565K	Hold	7,781	–	–	0.04%	291
2014 Q4	$537K	Buy	7,781 +1,586	+26%	+$107K	0.04%	289
2014 Q3	$402K	Buy	+6,195	New	+$392K	0.04%	269
2014 Q2	–	Sell	-6,355	Closed	-$374K	–	405
2014 Q1	$374K	Buy	6,355 +717	+13%	+$40K	0.04%	268
2013 Q4	$288K	Sell	5,638 -654	-10%	-$32.8K	0.03%	291
2013 Q3	$317K	Sell	6,292 -127	-2%	-$6.65K	0.04%	253
2013 Q2	$315K	Buy	+6,419	New	+$349K	0.04%	237

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

MAI Capital Management's LLY Position: Q1 2026 in Review

MAI Capital Management increased its Eli Lilly (LLY) stake by 5.2% in Q1 2026, buying an estimated $4.83M and bringing the position to 96,089 shares worth $88.4M. The position accounts for 0.5% of the portfolio, ranked #40.

MAI Capital Management first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. The position peaked at $98.1M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

MAI Capital Management held 96,089 shares of Eli Lilly worth $88.4M as of Q1 2026.
MAI Capital Management bought 4,767 Eli Lilly shares in Q1 2026, an estimated $4.83M.
Eli Lilly made up 0.5% of MAI Capital Management's portfolio in Q1 2026, its #40 holding.
MAI Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
MAI Capital Management's Eli Lilly position peaked at $98.1M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.